NASDAQ:CLYM | Cash Flow Statement | Climb Bio, Inc.

Complete source-backed cash-flow history.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$13.5M
2026-03-31-$13.72M$38,000.00-$14.38M-$12.96M$5,000.00
2025-12-31-$17.52M$30,000.00-$15.64M$0.00$25.54M-$21,000.00
2025-09-30-$12.89M
2025-06-30-$8.67M
2025-03-31-$20.78M$0.00-$15.43M-$42.75M$0.00
2024-12-31-$8.42M$0.00-$5.52M$0.00-$53.41M$41,000.00
2024-09-30-$8.9M
2024-06-30-$54.89M
2024-03-31-$1.7M-$1.82M$13.75M$15,000.00
2023-12-31-$3.64M-$947,000.00$36.75M$288,000.00
2023-09-30-$3.97M
2023-06-30-$5.22M
2023-03-31-$22.29M-$15.18M$5.8M$1,000.00
2022-12-31-$7.76M-$8.45M$14.28M$0.00
2022-09-30-$9.68M
2022-06-30-$14.6M
2022-03-31-$13.2M-$10.78M-$4.04M$0.00
2021-12-31-$10.55M-$7.88M-$8.05M$38,000.00
2021-09-30-$9.62M
2021-06-30-$8.72M
2021-03-31-$18.6M-$6.74M$0.00$34.08M
2020-12-31-$14.86M-$5.62M$8.08M$4.93M
2020-09-30-$2.26M
2020-06-30-$1.63M
2020-03-31-$1.92M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$59.85M$97,000.00-$54.36M$186,000.00$2.83M-$21,000.00
2024-12-31-$73.9M$0.00-$15.56M$0.00-$121.09M$130.73M
2023-12-31-$35.12M-$20.6M$68.98M$841,000.00
2022-12-31-$45.24M-$37.37M$34.44M$0.00
2021-12-31-$47.48M-$36.07M-$114.97M$177.23M
2020-12-31-$20.67M-$14.1M$8.08M$4.93M